Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Unum Therapeutics

Request full access

Developing our universal Antibody-Coupled T cell Receptor (ACTR, pronounced ‘actor’) therapy to address the limitations of other T cell approaches

Cambridge, United StatesFounded 2014Biotech & Life Sciences

About Unum Therapeutics

Cogent Biosciences, operating under the domain unumrx.com, is a biotechnology startup focused on developing precision therapies for genetically defined diseases. The company operates in the healthcare and biotechnology market, serving patients suffering from diseases that are directly linked to genetic mutations. These patients represent a significant portion of the global population and are in dire need of improved therapies to enhance their quality of life and survival rates.

Cogent's business model revolves around the discovery and development of novel, best-in-class, small molecule therapeutics. These are designed to improve upon existing drugs that have clear limitations and safety concerns. The company's primary revenue stream comes from the development and commercialization of these therapies.

The company's operations are based in Boulder, Colorado, where it has built a world-class discovery organization. Cogent is currently conducting several clinical trials, including Phase 2 SUMMIT and APEX trials, and a Phase 3 PEAK trial. The results of these trials, expected in the second half of 2023, will be crucial in determining the company's future trajectory.

Cogent is driven by a commitment to deliver novel precision therapies to patients with unmet medical needs. The company's passionate and dedicated team is focused on turning the promises of their therapies into reality, with the ultimate goal of transforming the lives of patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
293
Open positions
None listed
Dealroom signal
55.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Mar 2018 $86M — Undisclosed —
DEBTDebt Mar 2017 $15M — Square 1 Bank —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Unum Therapeutics website traffic

Latest recorded traffic for Unum Therapeutics is 2.5K monthly website visits, down 68.4% over the last three months. Unum Therapeutics's team grew 12.7% over the past year.

Latest monthly visits2.5K 3-month web change-68.4% 1-year team growth+12.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Unum Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Unum Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A12 investors entered at this stage

Series B and later1 investor entered at this stage

  • Square 1 Bank

Other known investors2 additional known investors

  • National University of Singapore
  • St Jude Children’s Research Hospital
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Unum Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Unum Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.